Your browser doesn't support javascript.
loading
Author Correction: The Rho GTPase Rnd1 suppresses mammary tumorigenesis and EMT by restraining Ras-MAPK signalling.
Okada, Tomoyo; Sinha, Surajit; Esposito, Ilaria; Schiavon, Gaia; López-Lago, Miguel A; Su, Wenjing; Pratilas, Christine A; Abele, Cristina; Hernandez, Jonathan M; Ohara, Masahiro; Okada, Morihito; Viale, Agnes; Heguy, Adriana; Socci, Nicholas D; Sapino, Anna; Seshan, Venkatraman E; Long, Stephen; Inghirami, Giorgio; Rosen, Neal; Giancotti, Filippo G.
Affiliation
  • Okada T; Cell Biology Program, Sloan-Kettering Institute for Cancer Research, Memorial Sloan-Kettering Cancer Center, New York, New York, 10065, USA.
  • Sinha S; Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, 10065, USA.
  • Esposito I; Cell Biology Program, Sloan-Kettering Institute for Cancer Research, Memorial Sloan-Kettering Cancer Center, New York, New York, 10065, USA.
  • Schiavon G; Cell Biology Program, Sloan-Kettering Institute for Cancer Research, Memorial Sloan-Kettering Cancer Center, New York, New York, 10065, USA.
  • López-Lago MA; Cell Biology Program, Sloan-Kettering Institute for Cancer Research, Memorial Sloan-Kettering Cancer Center, New York, New York, 10065, USA.
  • Su W; Breast Unit, Royal Marsden Hospital, London, SW3 6JJ, UK.
  • Pratilas CA; Cell Biology Program, Sloan-Kettering Institute for Cancer Research, Memorial Sloan-Kettering Cancer Center, New York, New York, 10065, USA.
  • Abele C; Department of Surgery and Center for Cell Engineering, Memorial Sloan-Kettering Cancer Center, New York, 10065, USA.
  • Hernandez JM; Cell Biology Program, Sloan-Kettering Institute for Cancer Research, Memorial Sloan-Kettering Cancer Center, New York, New York, 10065, USA.
  • Ohara M; Molecular Pharmacology and Chemistry Program, Sloan-Kettering Institute for Cancer Research, Memorial Sloan-Kettering Cancer Center, New York, New York, 10065, USA.
  • Okada M; Department of Pediatrics, Memorial Hospital, Memorial Sloan-Kettering Cancer Center, New York, New York, 10065, USA.
  • Viale A; The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland, 21287, USA.
  • Heguy A; Department of Biomedical Sciences and Human Oncology, Center of Experimental Medicine and Research, University of Torino, Torino, 10126, Italy.
  • Socci ND; Cell Biology Program, Sloan-Kettering Institute for Cancer Research, Memorial Sloan-Kettering Cancer Center, New York, New York, 10065, USA.
  • Sapino A; Department of Surgery, Memorial Hospital, Memorial Sloan-Kettering Cancer Center, New York, New York, 10065, USA.
  • Seshan VE; Department of Surgical Oncology, Research Institute for Radiation Biology and Medicine, Graduate School of Biomedical Sciences, Hiroshima University, Hiroshima, 734-8551, Japan.
  • Long S; Department of Surgical Oncology, Research Institute for Radiation Biology and Medicine, Graduate School of Biomedical Sciences, Hiroshima University, Hiroshima, 734-8551, Japan.
  • Inghirami G; Genomics Core Facility, Memorial Sloan-Kettering Cancer Center, New York, New York, 10065, USA.
  • Rosen N; Geoffrey Beene Translational Oncology Core Facility, Memorial Sloan-Kettering Cancer Center, New York, New York, 10065, USA.
  • Giancotti FG; Department of Pathology, Office for Collaborative Science, New York University, New York, 10016, USA.
Nat Cell Biol ; 21(4): 534, 2019 04.
Article in En | MEDLINE | ID: mdl-30842593
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Nat Cell Biol Year: 2019 Document type: Article Affiliation country: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Nat Cell Biol Year: 2019 Document type: Article Affiliation country: United States